arrow
J

Junya Matsumoto

japan institute for health security
H指数:22
被引数:1,850

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sex-stratified neuropsychiatric manifestations of post-COVID-19 condition: A Japanese National Registry of clinical and patient-reported outcomes (PSCORE-J)

后COVID-19状态按性别分层的神经精神表现:一项日本国家临床和患者报告结局注册研究(PSCORE-J)

2026-08-010
PRE
The introduction of measurement-based care for patients with schizophrenia may improve psychiatric symptoms and guideline adherence rate

为精神分裂症患者引入基于测量的护理可能改善精神症状和指南依从率

2026-05-080
OA
Eight-Year Progression of Clinical Practice Implementation Following Guideline Training in the EGUIDE Project

在EGUIDE项目中,指南培训后临床实践实施进展的八年评估

2026-03-010
PRE
Psychiatrists' Adherence to Guideline-Recommended Pharmacotherapy for Schizophrenia Affects Subcortical Structural Alterations in the Brains of Patients with Schizophrenia

精神科医师对指南推荐的精神分裂症药物治疗的依从性影响精神分裂症患者大脑的皮质下结构改变

2026-02-240
OAAI
Educational Spillover Effect within a Cluster: Impact of Guideline Education for Schizophrenia and Major Depressive Disorder on Psychiatrists’ Treatment Behavior in a Real-World Multicenter Study

集群内的教育溢出效应:在真实世界多中心研究中,关于精神分裂症和重度抑郁症的指南教育对精神科医生治疗行为的影响

2026-02-230
PRE
Long-Term Impact of EGUIDE Training on Facility-Wide Guideline Adherence Rate in Schizophrenia and Major Depressive Disorder: A Multicenter Study

EGUIDE培训对精神分裂症和重度抑郁症全院指南依从率的长期影响:一项多中心研究

2025-12-010
OAAI
Maintenance pharmacotherapy after electroconvulsive therapy in inpatients with major depressive disorder: 198 prescriptions in a real-world clinical setting

电休克治疗后住院重度抑郁症患者的维持期药物治疗:一项真实世界临床环境中的198例处方研究

2025-10-110
OAAI
EFFECT OF EDUCATION REGARDING TREATMENT GUIDELINES FOR SCHIZOPHRENIA AND DEPRESSION ON THE TREATMENT BEHAVIOR OF PSYCHIATRISTS: A MULTICENTER STUDY

关于精神分裂症和抑郁症治疗指南的教育对精神科医生治疗行为的影响:一项多中心研究

2025-02-120
OA
ASSOCIATIONS OF CLOZAPINE AVAILABLE INSTITUTION AND THE DIAGNOSIS OF SUBGROUPS ABOUT TREATMENT-RESISTANT SCHIZOPHRENIA OR NOT WITH A HIGHER RATE OF ANTIPSYCHOTIC MONOTHERAPY AND LOWER OTHER CONCOMITANT PSYCHOTROPICS IN OVERALL SCHIZOPHRENIA TREATMENT: A REAL-WORLD NATIONWIDE STUDY

氯氮平可用机构的关联性,以及是否为治疗难治性精神分裂症亚组诊断,与抗精神病药单一疗法较高率和总体精神分裂症治疗中其他合并精神药物较低率的关联:一项真实世界全国性研究

2025-02-120
OA
CHANGE OF PRESCRIPTION FOR PATIENTS WITH SCHIZOPHRENIA DURING ADMISSION: REAL-WORLD PRESCRIBING SURVEYS FROM THE EFFECTIVENESS OF GUIDELINES FOR DISSEMINATION AND EDUCATION PSYCHIATRIC TREATMENT PROJECT

精神分裂症患者入院期间的处方变更:来自《指南传播与教育精神科治疗项目》的真实世界处方调查

2025-02-120
OA
PROPOSAL FOR NOVEL PATIENT CLASSIFICATION WITH ENLARGED LATERAL VENTRICLES AND COGNITIVE DECLINE BASED ON DATA-DRIVEN ANALYSIS OF NEUROIMAGING IN PSYCHIATRIC DISORDERS AND CLINICAL CHARACTERIZATION

基于精神科疾病神经影像数据驱动分析及临床特征,提出针对伴有侧脑室扩大和认知衰退的新型患者分类方案

2025-02-120
OA
Electroconvulsive therapy-specific volume changes in nuclei of the amygdala and their relationship to long-term anxiety improvement in depression
2024-12-160
PRE